Staging Liver Fibrosis with Hepatic Perivascular Adipose Tissue as a CT Biomarker

Skylar Chan, Tejas Sudharshan Mathai, Praveen T.S. Balamuralikrishna, Vivek Batheja, Jianfei Liu, Meghan G Lubner, Perry J Pickhardt, Ronald Summers

Keywords: CT, Liver Fibrosis, Cirrhosis, Perivascular Adipose Tissue, Portal Vein

TL;DR: Biomarkers of the fat or perivascular adipose tissue (PVAT) surrounding the vessels in the liver (portal vein and other hepatic vessels) can be used to stage fibrosis.

Abstract: Cirrhosis is the 12th leading cause of death in the US. There are several CT imaging signs of late fibrosis, such as redistribution of liver segment volume, increased liver nodularity, and periportal space widening. Timely intervention can reverse the progression of early hepatic fibrosis, but later stages are irreversible. We hypothesize that the perivascular adipose tissue (PVAT) around the portal vein arising from periportal space widening may also be predictive of liver fibrosis. In this work, a fully automated pipeline was developed to segment the liver, spleen, portal vein and its branches. The PVAT in the vicinity of the portal vein was identified. From these structures, CT imaging biomarkers (volume, attenuation, fat fraction) were computed. They were used to build uni- and multivariate logistic regression models for diagnosing advanced fibrosis and cirrhosis. The best multivariate model for cirrhosis achieved 93.3% AUC, 78.9% sensitivity, and 93.4% specificity. For advanced fibrosis, the multivariate model obtained 88.7% AUC, 84.2% sensitivity, and 73.7% specificity. The automated approach may be useful for population-based studies of metabolic disease and opportunistic screening.

Primary Subject Area: Segmentation

Secondary Subject Area: Detection and Diagnosis

Paper Type: Validation or Application

Registration Requirement: Yes

Visa & Travel: Yes

Submission Number: 43